Evista vs Medroxyprogesterone: brand vs ingredient
Evista contains Raloxifene, while Medroxyprogesterone is a different active ingredient in the Progestin class. This page compares them: when each is used, how the mechanisms and indications differ, and whether the question "Evista vs Medroxyprogesterone" makes sense to ask at all.
What is the relationship?
Evista and Medroxyprogesterone are different things: Evista is a branded medication whose active ingredient is Raloxifene (in the Hormones and Birth Control class), whereas Medroxyprogesterone is in the Progestin class. They belong to different therapeutic classes and are chosen for different indications.
When Evista is used
Evista is approved for prevention and treatment of postmenopausal osteoporosis and for reduction of invasive breast cancer risk in postmenopausal women at increased risk.
When Medroxyprogesterone is used
MPA is approved for amenorrhoea, abnormal uterine bleeding due to hormonal imbalance, prevention of endometrial hyperplasia in postmenopausal women receiving estrogen, and prevention of pregnancy (depot formulation).
Mechanisms compared
Evista: Raloxifene binds estrogen receptors and produces tissue-selective effects: estrogen-agonist activity in bone (preserving bone mineral density) and on lipid metabolism (lowering LDL cholesterol), while exhibiting estrogen… Medroxyprogesterone: MPA binds progesterone receptors and produces strong progestational effects: thickening cervical mucus, inhibiting ovulation, thinning the endometrium and reducing hot flashes.
When the comparison makes sense
Comparing Evista with Medroxyprogesterone makes sense when both are in the same clinical decision: the prescriber has weighed both for different but related conditions. If the question is between two options for the same need, the prescriber decides based on prior response, comorbidities and tolerance.
Frequently asked questions
Do Evista and Medroxyprogesterone treat the same thing? ▾
No — they treat different conditions because they belong to different therapeutic classes. The question of which to use is for the prescriber to answer based on the specific indication.
Can Evista and Medroxyprogesterone be combined? ▾
It depends on the interaction profile of Raloxifene with Medroxyprogesterone. If both are in a single prescription, the prescriber has weighed it. Self-medicating with both is not recommended without pharmacist review.
Which is better, Evista or Medroxyprogesterone? ▾
"Better" doesn't apply between medications for different indications. The sensible question is which fits your specific clinical need — that is the prescriber's call.
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.